Tempest Therapeutics
TPSTInsider trades and stock quote 2024-2026
All insider trades at Tempest Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 3/24/2026 | Buy | Angel, Matthew | CEO and President | $2.2 | $500,001 |
| 8/12/2024 | Sell | Versant Venture Capital Vi, L.p. | Ten Percent Owner | $1.1 | $426,993 |
| 8/8/2024 | Sell | Versant Venture Capital Vi, L.p. | Ten Percent Owner | $1.4 | $540,040 |
| 7/3/2024 | Buy | Brady, Stephen R. | President and CEO | $2.1 | $73,850 |
| 7/2/2024 | Buy | Whiting, Samuel | Chief Medical Officer | $2.1 | $9,951 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)